JLE

European Journal of Dermatology

MENU

Exacerbation of livedoid vasculopathy after coronavirus disease 2019 Volume 32, issue 1, January-February 2022

Figures


  • Figure 1.
Authors
1 Department of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan
2 Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki-shi, Nagasaki, Japan
a These authors contributed equally

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 typically presents with fever, fatigue, myalgia, headache, diarrhoea, cough and dyspnoea [1], and was declared a pandemic by the World Health Organization on 11th March, 2020. Cutaneous manifestation of COVID-19 was first described as a “rash” and was observed in 0.2% of 1,099 hospitalized patients in China [2]. The reason why there were so few reports of cutaneous [...]